eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
10/2002
vol. 6
 
Share:
Share:
abstract:

Interleukin 15 - biological properties and antitumor activity

Jacek Mackiewicz
,
Michał Kasperkiewicz

Współcz Onkol (2002), vol. 6, 10, 632-636
Online publish date: 2003/03/26
View full text Get citation
 
IL-15 and IL-2 demonstrate similar biologic properties in vitro. They share a receptor component
(IL-2/15 βγ(c)) but have an unique specific a chain, which completes IL-αβγ and IL-2Rαβγ. The mechanism of signal transduction of these two cytokines is similar. IL-15 plays an essential role in the development of NK cells. Like IL-2, it activates antibody-dependent cellular cytotoxicity (ADCC). IL-15 stimulates NK cell cytokine and chemokine production [ (MIP)-1 α and β, INF-γ, GM-CSF], which is in-
creased with the co-stimulation of IL-12. The effect of combination of IL-15 and IL-12 on NK cells can be compared to IL-18 + IL-12. Monocytes/makrophages and granulocytes demonstrate an expression of high affinity to IL-15R. IL-15 has also an influence on TCR αβ. It directs monocyte differentiation into dendritic cells with features of Langerhans cells.
IL-15 bears a potential for clinical application in tumour immunotherapy. The IL-15 administration causes the expansion of NK cells, CD8+ cells and other non-classical subpopulations of T cells. Apoptosis caused by endothelial and tumour cells is essentially lower after the simulation with IL-15 than stimulation IL-2. IL-15 has also a beneficial influence on the restoration of cytokine type 1 and type 2 balance. IL-15 stimulates activity against many types of tumours, by activation of CD8+, NK cells, chemokines and cytokines. IL-15 also plays a role in the pathogenesis in various diseases including tumours.
IL-15 can also be useful as an adjuvant in anti-tumour vaccines.
keywords:

IL-15, NK cells, -immunotherapy, cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.